SF
IDXX icon

Summit Financial’s Idexx Laboratories IDXX Stock Holding History

Summit Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$823K Buy
1,464
+192
+15% +$123K 0.01% 840
2025
Q4 		$861K Sell
1,272
-319
-20% -$217K 0.01% 714
2025
Q3 		$1.02M Sell
1,591
-163
-9% -$98.9K 0.02% 653
2025
Q2 		$941K Sell
1,754
-57
-3% -$27.3K 0.02% 424
2025
Q1 		$761K Sell
1,811
-611
-25% -$265K 0.02% 424
2024
Q4 		$1M Sell
2,422
-110
-4% -$48.2K 0.04% 316
2024
Q3 		$1.28M Buy
2,532
+1,198
+90% +$582K 0.05% 225
2024
Q2 		$650K Buy
+1,334
New +$670K 0.03% 287

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit Financial's IDXX Position: Q1 2026 in Review

Summit Financial increased its Idexx Laboratories (IDXX) stake by 15% in Q1 2026, buying an estimated $123K and bringing the position to 1,464 shares worth $823K. The position accounts for 0.01% of the portfolio, ranked #840.

Summit Financial first reported a position in IDXX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.28M in Q3 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Summit Financial held 1,464 shares of Idexx Laboratories worth $823K as of Q1 2026.
  • Summit Financial bought 192 Idexx Laboratories shares in Q1 2026, an estimated $123K.
  • Idexx Laboratories made up 0.01% of Summit Financial's portfolio in Q1 2026, its #840 holding.
  • Summit Financial first reported a position in Idexx Laboratories in Q2 2024 and has held it in 8 quarters since.
  • Summit Financial's Idexx Laboratories position peaked at $1.28M in Q3 2024.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.